Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icotinib in Previously Treated Non/Light-smoking Patients With Squamous Lung Cancer
NCT02009605Phase 2Unknown
- Sponsor
- Zhejiang University
- Start
- Mar 2015
- Primary completion
- Jan 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of icotinib in squamous cell carcinoma of the lung (LSCC), sponsored by Zhejiang University. Status: unknown.
02
Drugs
icotinib
03
Conditions
squamous cell carcinoma of the lung (LSCC)
Beyond the preview
Go deeper on NCT02009605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02009605.